(-)-Norgestrel | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

(+-)-Norgestrel
US Exclusivities

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

(+-)-Norgestrel

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 28 USDMF, 11 CEP/COS, 4 JDMF, 6 EU WC, 20 NDC API, 15 Listed Suppliers, $ API Reference Price

46 API Suppliers
28 USDMF
11 CEP/COS
4 JDMF
6 EU WC
20 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

289 FDF Dossiers, 136 FDA Orange Book, 80 Europe, 30 Canada, 3 Australia, 21 South Africa, 19 Listed Dossiers

289 FDF Dossiers
136 FDA Orange Book
80 Europe
30 Canada
3 Australia
21 South Africa
19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A, SYSTEM;INTRAUTERINE - 52MG, TABLET;ORAL - 0.02MG;0.1MG, SYSTEM;INTRAUTERINE - 52MG, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR, TABLET;ORAL - 1.5MG

TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A
SYSTEM;INTRAUTERINE - 52MG
TABLET;ORAL - 0.02MG;0.1MG
SYSTEM;INTRAUTERINE - 52MG
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR
TABLET;ORAL - 1.5MG

RELATED EXCIPIENT COMPANIES

5 SPI Pharma, 2 Seqens, 7 DKSH, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 29 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 17 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 27 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 22 Direct Compression, 21 Thickeners and Stabilizers, 20 Granulation, 13 Lubricants & Glidants, 13 Solubilizers, 11 Co-Processed Excipients, 10 Taste Masking, 9 Empty Capsules, 8 Film Formers & Plasticizers, 7 Topical, 6 Chewable & Orodispersible Aids, 5 Parenteral, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Emulsifying Agents, 3 Rheology Modifiers

65 Fillers, Diluents & Binders
44 Coating Systems & Additives
27 Controlled & Modified Release
22 Disintegrants & Superdisintegrants
22 Direct Compression
21 Thickeners and Stabilizers
20 Granulation
13 Lubricants & Glidants
13 Solubilizers
11 Co-Processed Excipients
10 Taste Masking
9 Empty Capsules
8 Film Formers & Plasticizers
7 Topical
6 Chewable & Orodispersible Aids
5 Parenteral
5 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
4 Emulsifying Agents
3 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 79 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
79 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 67 Finished Drug Prices, 14 Annual Reports

6 US Medicaid Prescriptions
67 Finished Drug Prices
14 Annual Reports

MARKET PLACE

8 APIs, 5 FDF Dossiers

8 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 2 US Exclusivities

21 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

5 EDQM, 3 USP, 1 JP, 8 Others

5 EDQM
3 USP
1 JP
8 Others

$ API Ref.Price (USD/KG) : 5,683 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 1LABORATOIRE HRA

02 1MEDICINES360

filter Product Reset all filters

2 All

01 1LEVONORGESTREL

02 1NORGESTREL

filter Exclusivity Expiration Date Reset all filters

2 All

01 12026-06-29

02 12026-07-13

filter Exclusivity Code Reset all filters

2 All

01 1I-917

02 1RTO

Product Main Page

LABORATOIRE HRA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NORGESTREL

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

RTO

Exclusivity Expiration Date

2026-07-13

Application Number

17031

Product Number

1

Exclusivity Details

01

LABORATOIRE HRA

The Generic Rx Session

Not Confirmed

LABORATOIRE HRA

France

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : RTO

Exclusivity Expiration Date : 2026-07-13

Application Number : 17031

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

MEDICINES360

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

LEVONORGESTREL

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-917

Exclusivity Expiration Date

2026-06-29

Application Number

206229

Product Number

1

Exclusivity Details

02

MEDICINES360

The Generic Rx Session

Not Confirmed

MEDICINES360

U.S.A

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEVONORGESTREL

Exclusivity Code : I-917

Exclusivity Expiration Date : 2026-06-29

Application Number : 206229

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!